This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S.Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation 115: 2398-2409, 8 May 2007. Available from: URL: http://www.circ.ahajournals.org
Rights and permissions
About this article
Cite this article
High-dose statins of value for ACS, not so for CAD. Pharmacoecon. Outcomes News 529, 7 (2007). https://doi.org/10.2165/00151234-200705290-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705290-00017